Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer

The Number of Metastatic Lymph Nodes and the Ratio Between Metastatic and Examined Lymph Nodes Are Independent Prognostic Factors in Esophageal Cancer Regardless of Neoadjuvant Chemoradiation or Lymphadenectomy Extent

(2009) Christophe Mariette et al.   ANNALS OF SURGERY

Post-treatment Endoscopic Biopsy Is a Poor-Predictor of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer

(2009) Inderpal S. Sarkaria et al.   ANNALS OF SURGERY

Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

(2009) James M. Donahue et al.   ANNALS OF THORACIC SURGERY

Clinical and Pathologic Evaluation of the Effectiveness of Neoadjuvant Chemoradiation Therapy in Advanced Esophageal Cancer Patients

(2009) Yasunori Akutsu et al.   WORLD JOURNAL OF SURGERY

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis

(2008) E. Bollschweiler et al.   ANNALS OF ONCOLOGY

Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer

(2008) Paul M. Schneider et al.   ANNALS OF SURGERY

Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response

(2008) Andrew P. Barbour et al.   ANNALS OF SURGICAL ONCOLOGY

Extracapsular Lymph Node Involvement Differs Between Squamous Cell and Adenocarcinoma of the Esophagus

(2008) Ralf Metzger et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant Chemoradiation Versus Chemotherapy for Patients Undergoing Esophagectomy for Esophageal Cancer

(2008) Theresa D. Luu et al.   ANNALS OF THORACIC SURGERY

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY